Public Profile

United Smart Pharma

United Smart Pharma, often referred to as USP, is a prominent player in the pharmaceutical industry, headquartered in Egypt (EG). Established in 2010, the company has rapidly expanded its operations across the Middle East and North Africa, focusing on the development and distribution of high-quality pharmaceutical products. Specialising in generic medications and innovative healthcare solutions, United Smart Pharma is committed to enhancing patient care through its diverse portfolio. The company’s unique approach combines advanced research with stringent quality control, ensuring that its products meet international standards. With a strong market presence, United Smart Pharma has achieved significant milestones, including partnerships with leading healthcare providers and a growing reputation for reliability and excellence in the pharmaceutical sector. As a trusted name in the industry, USP continues to contribute to the health and well-being of communities across its operational regions.

DitchCarbon Score

How does United Smart Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

15

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

6

Industry Benchmark

United Smart Pharma's score of 15 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

United Smart Pharma's reported carbon emissions

United Smart Pharma, headquartered in Egypt (EG), currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Consequently, there are no documented reduction targets or climate commitments outlined by the company. In the absence of concrete emissions data, it is essential to note that many companies in the pharmaceutical industry are increasingly focusing on sustainability and climate action, often setting ambitious targets to reduce their carbon footprint. However, without specific commitments or initiatives from United Smart Pharma, it is unclear how they align with industry standards or climate goals.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. United Smart Pharma's primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. United Smart Pharma is headquartered in EG, which has a rank of medium, indicating medium grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

United Smart Pharma is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Health Services

CDP

Actylis

US
Health Services
Updated 10 days ago

UNILABS

FR
Health Services
Updated 10 days ago

United BioSource LLC

US
Health Services
Updated 10 days ago

Mettler-Toledo (Korea) Ltd.

KR
Health Services
Updated 4 days ago

Galenicum

ES
Health Services
Updated 10 days ago

Infiniti Nutraceuticals

US
Health Services
Updated 10 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers